We would love to hear your thoughts about our site and services, please take our survey here.
Ella they are options, expenses are largely £2 - 3m a year, but with acquisitions this will be higher this year. But with Casa we should see some cash this year I interpret as $5m. I hope the board really focus on the monies for the mine next year and getting this up and running.
Price action and that latest RNS which feels like people knew in advance, I dont believe a deal is going to be done by the EA end.
Now we open up to wider participants and let the majors battle one another, AA have had a chance and have blown it,
Dividend drops to 45p from 2023 onwards. https://www.gsk.com/media/7050/gsk-investor-update_23-06-21.pdf
There is nothing in this presentation that inspires me, but i did not watch the webinar for context.
A lot of the pipeline talks about investing in R&D but it seems to projects already in tray, looking to creating value by separating out and selling a stake at the top end of the value which is not too bad, but this is financial engineering.
Looking at more cost savings another £0.5bn a year.
It will be her decision if her strategy is to realign the cash to investing and from what i have read (Have to see what is finally said) then it is solely her strategy and she has already started mooting to big Institutions.
Will be interesting to see what the big guys do as a lot will already know of her plans and shared what they think.
Cant compare Divi All at sea, look at the SP growth.
Astra Share price more than doubled in the last 5 years, 10 Years Quadruppled
GSK is nearly down by c10% in the last 5 years , down 20% last 10
Yes Astra have not increased the dividend but shareholders have gained by the absolute returns. Now would you be happy of c 10% extra income, or 110% Growth last 5 years??
EW has been at GSK for last decade, see what her strategy is, i am in two minds, I dont think she is the right person going forward, but she has been making acquisitions of late and invested in VIR last year, albeit was it cheap or expensive jury is out. If VIR really does transform it would have been a masterstroke for GSK and she has credit as it was made under her watch.
Dont disagree and he made an a**e of himself during the 2008 crash, that Jon Stewart ridiculed him for.
https://www.youtube.com/watch?v=l9tclPuq6TY
https://www.thetimes.co.uk/article/the-questions-facing-walmsley-as-gsk-break-up-looms-h0wn756xf
Dame Emma Walmsley will today finally update the City on the strategy of GlaxoSmithKline at its eagerly awaited capital markets day.
At stake from the virtual event is the potential future independence of one of Britain’s largest drug groups, as well as the prospect of Walmsley, after four years in charge, continuing to lead “New GSK” beyond a planned break-up of the group.
Sponsored
Investors and analysts will be looking for clarity from a number of key questions at what Bank of America, GSK’s joint-house broker, has called an “important watershed for the company”.
https://www.cnbc.com/2021/06/22/jim-cramer-glaxosmithkline-investor-meeting-could-set-up-buyable-dip.html
CNBC’s Jim Cramer gave investors a primer on what to watch for when pharmaceutical giant GlaxoSmithKline holds an investor day Wednesday morning.
The British-based company currently pays out a 5.56% dividend to shareholders as CEO Emma Walmsley leads a reshuffling in the business.
“If the rumors are true and GlaxoSmithKline really takes a meat-ax to its dividend, then I think you need to be prepared for the stock to get slammed as income-oriented investors dump it,” he said Tuesday on “Mad Money.” “But after it sells off, you could get a good buying opportunity.”
Since she became CEO in April 2017, GlaxoSmithKline shares are down more than 7% at $39.08 as of Tuesday’s close, giving it a $93 billion market cap.
“If that’s really the plan, I think she’s misjudged her shareholder base. There are a lot of people who own big pharma stocks for the income; the last thing they want is a dividend cut,” Cramer said. “The dividend is literally the best thing about the stock — it’s called income.”
It will make money the bits, why i have held. I would have waited and thought you were going to as your looking at charts.
I suspect this will be a good strategy as the have consulted with the big boys and are under pressure. This for me is a solid long term company that needs to be rejuvenated. Have seen on twitter the break up is £50bn for each business so £100bn.
Wisha, what offer ? nothing has been disclosed externally yet, unless I have missed something.
If we dont get a spikey leak in the next 1.5 weeks ahead of the EA agreement end date, either we extend or have rejected an offer behind the scenes. Can not see this going to the wire.
Rothschild will be retained if no deal with AAL, they know they can do well here on any future deal.
Drilling is not expensive and depending on them targetting specific areas to hone in, then it can be done, for any AIM listed company shareholders are wary of dilution.
Would be risky if we was solely relying on AAL, but we are not as shorn has said, not long to go and we know what direction we are going in, deal or no deal, for me it is proving we are worth multiples to what we are now and i think the answer is yes.